Drug Discovery News
-
Axsome receives FDA Orphan Drug designation for narcolepsy drug
Drug Discovery | News | 0 Comment | 17 Oct, 2018
Singapore - Axsome Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for the mana...Read more
-
FDA issues new guidance for developers of complex generics
Drug Discovery | News | 0 Comment | 10 Oct, 2018
Singapore - The FDA has released new guidance documents aimed at advancing development of generic versio...Read more
-
Novartis’ crizanlizumab relieves patients from sickle cell pain crisis
Drug Discovery | News | 0 Comment | 10 Oct, 2018
Results from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab, a humanized anti-P-selectin monoclonal ...Read more
-
J&J abandons partnership for Geron’s cancer drug
Drug Discovery | News | 0 Comment | 04 Oct, 2018
Singapore - Johnson & Johnson has dissolved its four-year-old partnership with Geron for cancer drug imetelstat...Read more
-
New drug blocks pancreatic cancer growth
Drug Discovery | News | 0 Comment | 28 Sep, 2018
A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mi...Read more
-
Drug Discovery | News | 0 Comment | 26 Sep, 2018
Alexion Pharmaceuticals and Syntimmune have entered into a definitive agreement for Alexion to acquire Syntimmune, a cli...Read more
-
Anaeropharma Science signs research agreement with Astellas
Drug Discovery | News | 0 Comment | 25 Sep, 2018
Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...Read more
-
Accenture, Merck, Amazon partner to advance drug innovation and research
Drug Discovery | News | 0 Comment | 18 Sep, 2018
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...Read more
-
Pfizer receives Breakthrough Therapy designation for inhibitor drug
Drug Discovery | News | 0 Comment | 06 Sep, 2018
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...Read more
-
China approves first "Made in China" cancer drug
Drug Discovery | News | 0 Comment | 06 Sep, 2018
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...Read more
-
BeiGene Announces Acceptance of its First NDA for Zanubrutinib
Drug Discovery | News | 0 Comment | 28 Aug, 2018
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...Read more
-
FDA approves first drug for neurotrophic keratitis
Drug Discovery | News | 0 Comment | 23 Aug, 2018
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...Read more
-
Strides Pharma receives USFDA nod for two key ANDAs
Drug Discovery | News | 0 Comment | 22 Aug, 2018
India's Strides Pharma has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limite...Read more
-
GIC receives govt funding for immuno-oncology project
Drug Discovery | News | 0 Comment | 22 Aug, 2018
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...Read more
-
Roche's Alecensa receives 'priority review' designation from CNDA
Drug Discovery | News | 0 Comment | 21 Aug, 2018
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...Read more
-
HitGen collaborates with LG Chem
Drug Discovery | News | 0 Comment | 20 Aug, 2018
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...Read more
-
Blueberry Therapeutics raises £10M funding to develop nanomedicines
Drug Discovery | News | 0 Comment | 16 Aug, 2018
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...Read more
-
Multi- institutional alliance to develop anti-aging drugs
Drug Discovery | News | 0 Comment | 16 Aug, 2018
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...Read more
